↓ Skip to main content

Proteomic Methods in Neuropsychiatric Research

Overview of attention for book
Cover of 'Proteomic Methods in Neuropsychiatric Research'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients
  3. Altmetric Badge
    Chapter 2 Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer’s Disease
  4. Altmetric Badge
    Chapter 3 What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?
  5. Altmetric Badge
    Chapter 4 Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders
  6. Altmetric Badge
    Chapter 5 Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications
  7. Altmetric Badge
    Chapter 6 Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders
  8. Altmetric Badge
    Chapter 7 LC-MSE for Qualitative and Quantitative Proteomic Studies of Psychiatric Disorders
  9. Altmetric Badge
    Chapter 8 The Utility of Multiplex Assays for Identification of Proteomic Signatures in Psychiatry
  10. Altmetric Badge
    Chapter 9 Blood Sampling and Preparation Procedures for Proteomic Biomarker Studies of Psychiatric Disorders
  11. Altmetric Badge
    Chapter 10 Multiplex Immunoassay Profiling of Serum in Psychiatric Disorders
  12. Altmetric Badge
    Chapter 11 Sequential Immunoprecipitation of Secretory Vesicle Proteins from Biosynthetically Labelled Cells
  13. Altmetric Badge
    Chapter 12 2D Gel Electrophoresis of Insulin Secretory Granule Proteins from Biosynthetically Labelled Pancreatic Islets
  14. Altmetric Badge
    Chapter 13 Two-Dimensional Gel Electrophoresis: A Reference Protocol
  15. Altmetric Badge
    Chapter 14 A Two-Dimensional Difference Gel Electrophoresis (2D-DIGE) Protocol for Studies of Neural Precursor Cells
  16. Altmetric Badge
    Chapter 15 Identifying Biomarker Candidates in the Blood Plasma or Serum Proteome
  17. Altmetric Badge
    Chapter 16 Selective Reaction Monitoring Mass Spectrometry for Quantitation of Glycolytic Enzymes in Postmortem Brain Samples
  18. Altmetric Badge
    Chapter 17 A Selected Reaction Monitoring Mass Spectrometry Protocol for Validation of Proteomic Biomarker Candidates in Studies of Psychiatric Disorders
  19. Altmetric Badge
    Chapter 18 Application of iTRAQ Shotgun Proteomics for Measurement of Brain Proteins in Studies of Psychiatric Disorders
  20. Altmetric Badge
    Chapter 19 Co-immunoprecipitation for Deciphering Protein Interactomes
  21. Altmetric Badge
    Chapter 20 Sequential Co-immunoprecipitation and Immunoblot Approach to Determine Oligomerisation of G-Protein-Coupled Receptors
  22. Altmetric Badge
    Chapter 21 A Clinical Study Protocol to Identify Serum Biomarkers Predictive of Response to Antipsychotics in Schizophrenia Patients
  23. Altmetric Badge
    Chapter 22 A Protocol for Producing the Maternal Low-Protein Rat Model: A Tool for Preclinical Proteomic Studies
  24. Altmetric Badge
    Chapter 23 Generation of the Acute Phencyclidine Rat Model for Proteomic Studies of Schizophrenia
  25. Altmetric Badge
    Chapter 24 A Protocol for Generation of a Corticosterone Model of Psychiatric Disorders
  26. Altmetric Badge
    Chapter 25 MK-801-Treated Oligodendrocytes as a Cellular Model to Study Schizophrenia
  27. Altmetric Badge
    Chapter 26 Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders
  28. Altmetric Badge
    Chapter 27 SILAC Mass Spectrometry Profiling: A Psychiatric Disorder Perspective
  29. Altmetric Badge
    Chapter 28 Preparation of Peripheral Blood Mononuclear Cells (PBMCs) as a Model for Proteomic Studies of Psychiatric Disorders
  30. Altmetric Badge
    Chapter 29 Proteomic Profiling of Skin Fibroblasts as a Model of Schizophrenia
  31. Altmetric Badge
    Chapter 30 Proteomic Profiling of the Pituitary Gland in Studies of Psychiatric Disorders
  32. Altmetric Badge
    Chapter 31 Development of an Assay for Measuring Proprotein-Conversion Activity on a Multiplex Magnetic Bead-Based Array Platform
  33. Altmetric Badge
    Chapter 32 Phenotyping Multiple Subsets of Immune Cells In Situ in Formalin-Fixed, Paraffin-Embedded Tissue Sections
  34. Altmetric Badge
    Chapter 33 Lab-on-a-Chip Proteomic Assays for Psychiatric Disorders
  35. Altmetric Badge
    Chapter 34 Development of a User-Friendly App for Testing Blood Coagulation Status in Schizophrenia Patients
  36. Altmetric Badge
    Chapter 35 Proteomic Approaches to Enable Point-of-Care Testing and Personalized Medicine for Psychiatric Disorders
Attention for Chapter 26: Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders
Chapter number 26
Book title
Proteomic Methods in Neuropsychiatric Research
Published in
Advances in experimental medicine and biology, March 2017
DOI 10.1007/978-3-319-52479-5_26
Pubmed ID
Book ISBNs
978-3-31-952478-8, 978-3-31-952479-5
Authors

Giuliana S. Zuccoli, Daniel Martins-de-Souza, Paul C. Guest, Stevens K. Rehen, Juliana Minardi Nascimento, Zuccoli, Giuliana S., Martins-de-Souza, Daniel, Guest, Paul C., Rehen, Stevens K., Nascimento, Juliana Minardi

Editors

Paul C. Guest

Abstract

The mechanisms underlying the pathophysiology of psychiatric disorders are still poorly known. Most of the studies about these disorders have been conducted on postmortem tissue or in limited preclinical models. The development of human induced pluripotent stem cells (iPSCs) has helped to increase the translational capacity of molecular profiling studies of psychiatric disorders through provision of human neuronal-like tissue. This approach consists of generation of pluripotent cells by genetically reprogramming somatic cells to produce the multiple neural cell types as observed within the nervous tissue. The finding that iPSCs can recapitulate the phenotype of the donor also affords the possibility of using this approach to study both the disease and control states in a given medical area. Here, we present a protocol for differentiation of human pluripotent stem cells to neural progenitor cells followed by subcellular fractionation which allows the study of specific cellular organelles and proteomic analysis.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 25%
Other 2 17%
Student > Ph. D. Student 2 17%
Student > Doctoral Student 1 8%
Professor 1 8%
Other 1 8%
Unknown 2 17%
Readers by discipline Count As %
Medicine and Dentistry 3 25%
Biochemistry, Genetics and Molecular Biology 2 17%
Agricultural and Biological Sciences 2 17%
Business, Management and Accounting 1 8%
Neuroscience 1 8%
Other 0 0%
Unknown 3 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2017.
All research outputs
#17,886,132
of 22,963,381 outputs
Outputs from Advances in experimental medicine and biology
#3,110
of 4,958 outputs
Outputs of similar age
#220,492
of 308,769 outputs
Outputs of similar age from Advances in experimental medicine and biology
#44
of 78 outputs
Altmetric has tracked 22,963,381 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,958 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,769 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.